Recent News

For University of Vermont-related news, see below. For MaineHealth news, click here.

  • UVM Invests Holcombe as Inaugural J. Walter Juckett Chair in Cancer Research
    November 3, 2021 by Christina Davenport
    With $3 million in support from a longtime major supporter of the University of Vermont Cancer Center, Randall F. Holcombe, M.D., M.B.A., was invested as the inaugural J. Walter Juckett Chair in Cancer Research in the Larner College of Medicine on November 3.
  • Larner Awarded Full 8-Year LCME Accreditation
    November 3, 2021 by Ed Neuert
    The Larner College of Medicine at the University of Vermont has been awarded continued accreditation for a full eight-year term by the Liaison Committee on Medical Education (LCME), the accrediting body for all M.D. degree programs in the U.S. and Canada.
  • 2021 Celebration of Research Excellence Highlights Accomplishments at Larner
    October 29, 2021 by Jennifer Nachbur
    The University of Vermont’s Larner College of Medicine held a successful Dean's Excellence in Research Celebration October 25-27, shining a light on the hard work and achievements of students, faculty, staff, and alumni.
  • Emmett Whitaker, M.D. Receives Mentored Research Training Grant
    October 29, 2021 by Vermont Center for Cardiovascular and Brain Health
    Congratulations to Dr. Emmett Whitaker for being awarded a 2021 Foundation for Anesthesia Education and Research Mentored Research Training Grant (MRTG).
  • UVM Cancer Center Research Leads to First-of-Its-Kind Clinical Trial of Mesothelioma Treatment
    October 26, 2021 by Katherine Strotmeyer
    Linked to occupational asbestos exposure, malignant mesothelioma (MM) is an aggressive cancer arising primarily from the outer lining of the lungs with a dismal five-year survival rate of only five to 10 percent. Since 2004, only two therapies have been approved for the treatment of MM, which affects about 3,000 people a year in the United States. Now a promising new therapy for mesothelioma and metastatic cancer, arising from laboratory investigations at the University of Vermont, is about to enter a Phase I clinical trial.

Want to be our next news story?

Have you started a cool new project? Published a paper? Won an award? We want to hear from you! Contact us to be highlighted on our website, in our newsletters, and/or in our press releases.

Check out our newsletter archive:

December 2021

March 2022

August 2022

SpecialEditionAug2022

June 2023

Fall 2023

Winter 2024

Spring 2024

Summer 2024

Questions?

Please email us with any questions or for assistance accessing services.

Become a Member

All NNE-CTR members have access to our services and support. Learn more about the free benefits of membership, and join today!